Cardiol Therapeutics: First-Mover In CBD-Based Treatment For Heart Disease

Cardiol Therapeutics’ lead drug CardiolRx undergoing clinical trials for Pericarditis and Myocarditis. See why I rate CRDL stock as a strong buy.